Dan Sheng
Director/Board Member en BEIJING STRONG BIOTECHNOLOGIES,INC. .
Fortuna: 947 146 $ al 31/03/2024
Perfil
Dan Sheng has held multiple positions throughout her career.
Currently, she is the Director & Executive Deputy General Manager at Beijing Strong Biotechnologies, Inc. since 2016.
She is also a Member-Supervisory Board at Fuzhou Maixin Biotech Co., Ltd.
since 2020.
In terms of education, Dr. Sheng holds an MBA from The University of Chicago, which she obtained in 2012.
She also has a doctorate degree from New York University, conferred in 2004.
Additionally, she completed her undergraduate studies at the University of Science & Technology of China in 2000.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/05/2023 | 354 687 ( 0.11% ) | 947 146 $ | 31/03/2024 |
Cargos activos de Dan Sheng
| Empresas | Cargo | Inicio |
|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Director/Board Member | 13/08/2020 |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 30/09/2020 |
Formación de Dan Sheng.
| The University of Chicago | Masters Business Admin |
| New York University | Doctorate Degree |
| University of Science & Technology of China | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
- Bolsa de valores
- Insiders
- Dan Sheng
